Single-focussed versus integrated cognitive behaviour therapy for co-occurring depression and alcohol use problems

这项研究是重要和及时的，因为它提出了一个大规模的随机对照试验的认知行为疗法（CBT）的人同时发生抑郁症和酒精使用问题。迄今为止，很少有研究人员在这一人群中进行研究，其复杂的表现使得治疗提供者难以选择和提供有效的治疗方案。因此，尽管抑郁症和酒精使用问题的发生率在我们的社区正在增加，但仍然不清楚如何最好地管理和治疗这群人。通常情况下，人们通常会接受治疗的一部分，他们的介绍，例如他们的抑郁症或酒精使用问题。然而，这是罕见的两个条件，以综合的方式处理。心理治疗也是如此。迄今为止的研究项目已经探索了在没有共同发生的情况下有效治疗抑郁症和酒精使用的方法。目前还不知道同时存在酒精使用问题和抑郁症的人对单一焦点治疗的反应如何。此外，目前还不清楚将酒精使用和抑郁治疗方法结合起来是否会带来额外的好处。因此，这项研究是重要的，因为它是第一个探索有效的治疗方法的人与共同发生的抑郁症和酒精使用问题之一。这些问题的解决将更好地告知临床医生在精神健康和酒精-其他药物环境中的治疗选择。重要的是，这将有可能改善治疗与抑郁症和物质使用问题患者之间的匹配，这是社区环境中遇到的临床流行人群。

This study is significant and timely in that it proposes a large-scale randomised controlled trial of cognitive behaviour therapy (CBT) for people with co-occurring depression and alcohol use problems. To date, very few researchers have conducted research within this population, whose complex presentation makes it difficult for treatment providers to select and deliver effective treatment programs. Thus, although rates of depressive disorders and alcohol use problems are on the increase in our community, it is still not clear how best to manage and treat this group of people. Typically, people will often receive treatment for one part of their presentation, for example their depression or alcohol use problem. However, it is uncommon for the two conditions to be treated in an integrated way. This is certainly true for psychological treatments. Research programs to date have explored effective treatments for depression and alcohol use in the absence of the co-occurring condition. Currently it is not known how well people with co-occurring alcohol use problems and depression respond to treatments with a singular focus. Furthermore, it is not known whether integrating both alcohol use and depressive treatment approaches provides any additional benefit. This study is therefore significant, as it is one of the first to explore effective treatment approaches among people with co-occurring depressive and alcohol use problems. Resolution of these issues will better inform the treatment choices of clinicians practicing in both mental health and alcohol-other drug settings. Importantly, this will potentially improve the match between treatment and people with depression and substance use problems, a clinically prevalent population encountered in community settings.